Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2000
12/27/2000CN1277848A Traditional Chinese medicinal prepns. for treating osteoporosis
12/27/2000CN1059905C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
12/27/2000CN1059834C Pure traditional Chinese medicinal liquor with antisenile action
12/27/2000CN1059808C Powder for fracture and trauma
12/27/2000CN1059807C Spur pain-removing plaster
12/26/2000US6166206 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections
12/26/2000US6166077 Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
12/26/2000US6166064 Antiinflammatory agents; antiarthritic agents
12/26/2000US6166009 For clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which c-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6165996 Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis
12/26/2000US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis
12/26/2000US6165748 Useful in the modulation of cellular formation, growth, differentiation, proliferation and/or maintenance of a variety of adult and embryonic tissues and organs
12/26/2000US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist
12/26/2000US6165515 Administering to the osteoporosis patient an effective amount of an extract from inflammatory tissue of rabbit skin inoculated with vaccinia virus, which is protein free hygroscopic powder, and is positive for ninhydrin reaction
12/21/2000WO2000077256A1 48 human secreted proteins
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000076972A1 N-cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076971A2 Serine protease inhibitors
12/21/2000WO2000076552A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076517A1 Il-8 receptor antagonists
12/21/2000WO2000076516A1 Il-8 receptor antagonists
12/21/2000WO2000076515A1 Il-8 receptor antagonists
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076501A1 Il-8 receptor antagonists
12/21/2000WO2000076495A1 Il-8 receptor antagonists
12/21/2000WO2000076457A2 Il-8 receptor antagonists
12/21/2000WO2000066736B1 Growth factor homolog zvegf4
12/21/2000WO2000047580A3 Phenyl urea and phenyl thiourea derivatives
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000044391A3 Plasminogen kringle 4 region fragments and methods of use
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2382185A1 48 human secreted proteins
12/21/2000CA2377397A1 Il-8 receptor antagonists
12/21/2000CA2377391A1 Il-8 receptor antagonists
12/21/2000CA2377386A1 Il-8 receptor antagonists
12/21/2000CA2377341A1 Il-8 receptor antagonists
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376933A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways
12/21/2000CA2375920A1 Compounds
12/20/2000EP1061077A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient
12/20/2000EP1060193A2 Cd147 binding molecules as therapeutics
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060181A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
12/20/2000EP1060175A2 Tryptase inhibitors
12/20/2000EP1060171A2 Tryptase inhibitors
12/20/2000EP1060164A1 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists
12/20/2000EP1060161A1 Matrix metalloproteinase inhibitors
12/20/2000EP1059933A1 Method of increasing bone toughness and stiffness and reducing fractures
12/20/2000EP1059920A1 Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277605A Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors
12/20/2000CN1277061A Preparation of oral collagen with gradient molecular weight
12/20/2000CN1277051A Recipe of externally applied Chinese medicine for rheumatism and asthma
12/20/2000CN1277042A Prolifration treating bolus
12/20/2000CN1059596C 搽剂 Liniment
12/20/2000CN1059594C Chinese herbal medicine for treating osteoproliferation and other bone diseases and its preparing method
12/20/2000CN1059593C Bony spur pain-relieving plaster and its preparing method
12/20/2000CN1059587C Chinese patent drug for treating cervical vertebra disease
12/20/2000CN1059584C Pill for removing rheumatism
12/20/2000CN1059572C Medicine for treating rheumatoid and osteoproliferation and its preparing method
12/20/2000CN1059560C A Chinese herb medicine for curing Bi zheng
12/20/2000CN1059559C Oral medicine for curing osteonosus and producing process thereof
12/20/2000CN1059557C A medical preparation containing goose egg for treating osteoproliferation
12/20/2000CN1059555C Preparation for compound sodium fulvate injecta
12/19/2000US6162830 Antihistamines, antiallergens, bone disorders
12/19/2000US6162808 Compounds
12/19/2000US6162791 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/19/2000US6162790 Oligopeptides
12/19/2000CA2189527C Novel elastase inhibitors
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075290A1 Method for multiplying stem cells
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
1 ... 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 ... 820